Stage 2 Meaningful Use final rule goes to OMB

The Centers for Medicare & Medicaid Services sent the final rule implementing Stage 2 of the Meaningful Use program to the Office of Management and Budget (OMB) for review July 16, according to Health Data Management. The proposed rule had been issued in February. All proposed and final rules must be reviewed by OMB before they are released. OMB has 90 days to review the rule, which means that the final rule should be expected no later than mid-October. However, both OMB and the U.S. Department of Health & Human Services can ask that the review be extended. For instance, HHS sent the final rule implementing changes to HIPAA in the HITECH Act on March 24, and requested an indefinite extension on June 22. Article

Suggested Articles

Roche, which already owned a 12.6% stake in Flatiron Health, has agreed to buy the health IT company for $1.9 billion.

Allscripts managed to acquire two EHR platforms for just $50 million by selling off a portion of McKesson's portfolio for as much as $235 million.

Artificial intelligence could help physicians predict a patient's risk of developing a deadly infection.